This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Mclean Hospital Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anju Vasudevan: Innovator in Neuropsychiatric Therapy
Introduction
Anju Vasudevan is a pioneering inventor based in Waltham, MA (US). She has made significant contributions to the field of neuropsychiatric disorders through her innovative research and patented therapies. Her work focuses on the generation of human forebrain endothelial cells, which play a crucial role in treating various neuropsychiatric conditions.
Latest Patents
Anju Vasudevan holds a patent titled "Human periventricular endothelial cell therapy for neuropsychiatric disorders." This patent describes methods for generating human forebrain endothelial cells and outlines compositions comprising these cells. The methods include the addition of GABA and WNT7A for efficient differentiation, as well as the isolation of GABRB37CD31+ cell populations using FACS. This groundbreaking work has the potential to transform therapeutic approaches for neuropsychiatric disorders.
Career Highlights
Anju Vasudevan is affiliated with the McLean Hospital Corporation, where she continues to advance her research in neuropsychiatric therapies. Her dedication to innovation and her expertise in the field have positioned her as a leading figure in the development of new treatment methodologies.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Anju Vasudevan's contributions to the field of neuropsychiatric disorders through her innovative patent and research at McLean Hospital Corporation highlight her role as a significant inventor in the medical community. Her work promises to pave the way for new therapeutic options in treating complex neuropsychiatric conditions.